SARS-CoV-2 convalescent plasma: Clinical Trials

5 trials of SARS-CoV-2 convalescent plasma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 4 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 12Completed 2
Phase 32Completed 1, Unknown 1

Follow SARS-CoV-2 convalescent plasma: new trials by email Literature Review of SARS-CoV-2 convalescent plasma trials Research Report on SARS-CoV-2 convalescent plasma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19
SARS-CoV-2 convalescent plasma - Covid19, Immuno-Deficiency
Phase 3UnknownUniversity Hospital, Geneva1002021-04-082021-04-08
Convalescent Plasma for Treatment of COVID-19
SARS-CoV-2 convalescent plasma, Standard of care - Covid19
Phase 2 / Phase 3CompletedJoakim Dillner592020-12-032022-02-09
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
SARS-CoV-2 convalescent plasma, Plasma from a volunteer donor - SARS-CoV 2
Phase 2CompletedJohns Hopkins University12252020-06-032023-06-02
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
SARS-CoV-2 convalescent plasma - COVID-19
Phase 1 / Phase 2CompletedJoakim Dillner102020-05-072021-12-03
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)
SARS-CoV-2 convalescent plasma - COVID-19
Phase 1 / Phase 2CompletedJoakim Dillner102020-04-102021-12-16

Conditions studied

COVID-19 (5)  ·  Frailty (1)  ·  Viremia (1)

Sponsors

Joakim Dillner (3)  ·  Johns Hopkins University (1)  ·  University Hospital, Geneva (1)

Countries

Sweden (3)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Johan Ursing, MD, PhD (2)  ·  David J Sullivan, MD (1)  ·  Enos Bernasconi, MD (1)  ·  Laurent Kaiser, MD (1)  ·  Maja Weisser, MD (1)

Results publications

PMID 34880010, PMID 34981068, PMID 35353960, PMID 36722044, PMID 37131659, PMID 38483534

NIH funding

R01AI152078 (1), U24TR001609 (1), UL1TR003098 (1)